Genomic medicine developer Beam will raise $180m in a upsized initial public offering three years after being spun out of Harvard University.

Alphabet, Editas and Bio Palette-backed genomic medicine developer Beam will raise $180m in an upsized initial public offering three years after being spun out of Harvard University.

The Target-backed mattress and bedding brand is floating at the bottom of its range, at a valuation of less than half that of its last funding round.

Tokyo’s Mothers Market has approved an IPO for the business knowledge-sharing platform that would allow CyberAgent, DA Consortium and Mizuho Bank to exit.

CU Boulder spinout ALD NanoSolutions has merged with its peer Forge Nano, with new merged company securing $20m from a range of corporates.

Patrizia has paid an undisclosed amount to buy the real estate investment platform, whose investors included Aareal Bank and Berlin Hyp.

Chalmers University of Technology-founded baby ventilation monitor developer Monivent will join the Spotlight Stock Market in an IPO where 60% of shares have advance subscriptions in place.

University of Pennsylvania-linked CNS disorder-focused drug developer Passage Bio has filed to raise up to $125m having raised $226m in funding.

The cancer therapy developer is set to raise between $140m and $160m in its initial public offering, following $226m in funding.

The Sanofi-backed cancer therapy developer is set to raise between $140m and $160m in its initial public offering following $226m in funding.